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Abstract
Background:  STOP-BANG  score  (snore;  tired;  observed  apnea;  arterial  pressure;  body  mass
index; age;  neck  circumference  and  gender)  can  predict  the  risk  of  a  patient  having  Obstruc-
tive Syndrome  Apnea  (OSA).  The  aim  of  this  study  was  to  evaluate  the  incidence  STOP-BANG
score ≥  3,  in  surgical  patients  admitted  to  the  Post-Anesthesia  Care  Unit  (PACU).
Methods: Observational,  prospective  study  conducted  in  a  post-anesthesia  care  unit  (PACU)
during three  weeks  (2011).  The  study  population  consisted  of  adult  patients  after  noncardiac
and non-neurological  surgery.  Patients  were  classiﬁed  as  high  risk  of  OSA  (HR-OSA)  if  STOP-BANG
score ≥  3  and  Low-risk  of  OSA  (LR-OSA)  if  STOP-BANG  score  <  3  (LR-OSA).  Patient  demographics,
intraoperative  and  postoperative  data  were  collected.  Patient  characteristics  were  compared
using Mann--Whitney  U-test,  t-test  for  independent  groups,  and  chi-square  or  Fisher’s  exact
test.
Results: A  total  of  357  patients  were  admitted  to  PACU;  340  met  the  inclusion  criteria.  179
(52%) were  considered  HR-OSA.  These  patients  were  older,  more  likely  to  be  masculine,  had
higher BMI,  higher  ASA  physical  status,  higher  incidence  of  ischemic  heart  disease,  heart  fail-
ure, hypertension,  dyslipidemia  and  underwent  more  frequently  insulin  treatment  for  diabetes.
These patients  had  more  frequently  mild/moderated  hypoxia  in  the  PACU  (9%  vs.  3%,  p  =  0.012)
and had  a  higher  incidence  of  residual  neuromuscular  blockade  (NMB)  (20%  vs.  16%,  p  =  0.035).
Patients with  HR-OSA  had  a  longer  hospital  stay.
Conclusions:  Patients  with  HR-OSA  had  an  important  incidence  among  patients  scheduled  forse  patients  had  more  co-morbidities  and  were  more  prone  to  post-surgery in  our  hospital.  The
operative complications.
©  2012  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  España,  S.L.  All  rights
reserved.
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PALAVRAS-CHAVE
Apneia  obstrutiva
do  sono;
Pontuac¸ão
STOP-BANG;
Cirurgia;
Complicac¸ões
pós-operatórias
Doentes  com  alto  risco  de  Apneia  Obstrutiva  do  Sono:  complicac¸ões  respiratórias
pós-operatórias
Resumo
Introduc¸ão:  A  pontuac¸ão  no  STOP-BANG  (Snore,  Tired,  Observed  apnea,  blood  Pressure)  pode
prever o  risco  de  um  doente  ter  Síndrome  da  Apneia  Obstrutiva  Sono  (SAOS).  O  objetivo  deste
estudo foi  avaliar  a  incidência  da  pontuac¸ão  STOP  BANG>  3,  em  pacientes  cirúrgicos  internados
na Unidade  de  Cuidados  Pós-Anestésica  (UCPA).
Métodos:  Estudo  observacional  e  prospectivo  conduzido  numa  UCPA,  durante  três  semanas
(2011).  A  populac¸ão  de  estudo  consistiu  em  doentes  adultos  após  cirurgia  não  cardíaca  e  não
neurológica.  Os  doentes  foram  considerados  com  alto  risco  de  SAOS  (AR-SAOS)  se  tinham  um
score de  STOP-BANG  ≥3  e  de  baixo  risco  de  SAOS  (BR-SAOS)  se  tinham  score  de  STOP-BANG
<3. Foram  avaliados  dados  demográﬁcos  dos  doentes  e  colhidas  variáveis  intraoperatórias  e
pós-operatórias.  As  características  dos  doentes  foram  comparadas  através  do  teste  de  Mann-
Whitney, teste  t,  qui-quadrado  ou  teste  exato  de  Fisher.
Resultados:  Um  total  de  357  doentes  foram  admitidos  de  UCPA  e  340  preencheram  os  critérios
de inclusão.  Cento  e  setenta  e  nove  (52%)  tinham  AR-SAOS.  Estes  doentes  eram  mais  velhos,
tinham maior  probabilidade  de  serem  do  sexo  masculino,  tinham  um  Índice  Massa  Corporal
superior, tiveram  uma  classiﬁcac¸ão  maior  no  estado  físico  American  Society  Anesthesiologists,
uma maior  incidência  de  doenc¸a  cardíaca  isquémica,  insuﬁciência  cardíaca,  hipertensão,  dis-
lipidemia e  eram  mais  frequentemente  doentes  com  diabetes  em  tratamento  com  insulina.
Esses doentes  tiveram  mais  frequentemente  hipóxia  leve/moderado  na  UCPA  (9%  versus  3%,
P =  0,012)  e  tiveram  maior  incidência  de  bloqueio  neuromuscular  residual  (NMB)  (20%  versus
16%, P  =  0,035).  Os  doentes  com  AR-SAOS  tiveram  maior  tempo  de  internamento  hospitalar.
Conclusões:  Os  doentes  com  AR-SAOS  tem  uma  alta  incidência  entre  os  doentes  submetidos  a
intervenc¸ões cirúrgicas  programadas  no  nosso  hospital.  Esses  doentes  tinham  mais  comorbili-
dades e  foram  mais  propensos  a  ter  complicac¸ões  pós-operatórias.
© 2012  Sociedade  Portuguesa  de  Pneumologia.  Publicado  por  Elsevier  España,  S.L.  Todos  os
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Introduction
Obstructive  sleep  apnea  (OSA)  is  a  common  medical  condi-
tion  affecting  2--26%  of  the  general  population  and  it  is
the  most  prevalent  breathing  disturbance  in  sleep.1,2 OSA
is  characterized  by  repeated  complete  or  partial  collapse
of  the  pharyngeal  airway  during  sleep,  causing  cessation  of
airﬂow  (apnoea)  or  shallow  breathing  (hypopnea).  This  pat-
tern  of  sleep  arousal,  coupled  with  intermittent  hypoxemia,
is  associated  with  serious  adverse  cardiovascular  outcomes,
including  strokes,  and  leads  to  daytime  somnolence  and
compromised  neurocognitive  function.3
The  prevalence  of  OSA  in  the  surgical  population  is  higher
than  in  the  general  population  and  it  can  vary  widely  accord-
ing  to  the  underlying  medical  condition.3 In  particular,  as
many  as  70%  of  patients  undergoing  bariatric  surgery  were
found  to  have  OSA.4 OSA  has  been  recognized  as  a  potential
independent  risk  factor  for  adverse  perioperative  outcome.5
Compared  to  non-OSA  patients,  OSA  patients  undergoing
surgical  procedures  are  vulnerable  to  postoperative  airway
obstruction,6 myocardial  ischemia  congestive  heart  failure,
stroke  and  oxygen  desaturation.5,7,8
The  gold  standard  for  the  diagnosis  of  OSA,  polysomno-
graphy  (PSG),  is  impracticable  as  a  routine  preoperative
assessment  tool  for  OSA  because  it  is  an  expensive  and  labor
intensive  test.5 Many  tools  have  been  proposed  for  screening
patients  for  OSA  such  as  the  Berlin  questionnaire,  the  STOP
questionnaire  and  the  American  Society  of  Anaesthesiolo-
gists  (ASA)  checklist  --  and  the  use  of  these  tools  improves
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whe  likelihood  of  identifying  OSA  preoperatively.3 The  STOP
uestionnaire,  showed  a  high  sensitivity  for  detecting  OSA
when  score  is  ≥3):  93%  and  100%  for  moderate  and  severe
SA,  respectively;  however,  the  speciﬁcity  at  the  same  cut-
ff  is  low:  47%  and  37%  for  moderate  and  severe  OSA,
espectively,  resulting  in  high  false-positive  rates.  The  STOP
uestionnaire  is  a scoring  model  consisting  of  8  easily  admin-
strated  questions  starting  with  the  acronym  STOP-BANG
Appendix)  and  is  scored  based  on  Yes/No  answers  (scores
/0).1
The  aim  of  this  study  was  to  evaluate  the  incidence  of
atients  with  a  STOP-BANG  score  ≥  3,  in  surgical  patients
dmitted  in  the  Post-Anesthesia  Care  Unit  (PACU).
ethods
ubjects  and  settings
thical  approval  for  this  study  was  provided  by  the  Ethics
ommittee  of  Centro  Hospitalar  São  João,  Porto,  Portugal.
ritten  informed  consent  was  obtained  from  all  partici-
ants.
Centro  Hospitalar  São  João,  Porto,  is  an  1124-bed  ter-
iary  hospital  in  a  major  metropolitan  area  that  serves
,000,000  people.  This  prospective  study  was  conducted
n  a  12-bed  PACU  over  a  3-week  period  (from  May  9th  to
ay  27th,  2011).  Every  patient  admitted  to  the  PACU  who
as  able  to  provide  written  informed  consent  was  included
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n  the  study.  Exclusion  criteria  were  patient  refusal,  inca-
acity  to  provide  informed  consent,  a  score  of  <25  in
he  mini-mental  state  examination  (MMSE),  under  18  years
f  age,  foreign  nationality,  known  neuromuscular  disease,
rgent/emergent  surgery  and  cardiac  surgery,  neurosurgery
r  other  procedures  that  required  therapeutic  hypothermia.
All  the  patients  were  asked  to  complete  the  STOP  ques-
ionnaire.  Information  concerning  body  mass  index  (BMI)
ge,  neck  circumference,  and  gender  (Bang)  were  collected
y  a  research  assistant.
Patients  were  classiﬁed  as  being  at  high  risk  for  obstruc-
ive  sleep  apnea  (HR-OSA)  if  their  STOP-BANG  score  was  3
r  greater  and  as  being  at  low  risk  of  OSA  (LR-OSA)  if  their
core  was  less  than  3.
The  anesthesiologist  in  charge  was  blinded  to  patient
nvolvement  in  the  study.  Anesthesia  was  provided  and
onitored  according  to  the  anesthesiologist  in  charge  cri-
eria,  but  this  conduct  followed  minimum  departmental
tandards.  Neuromuscular  blocking  drugs  (NMBD)  were  used
or  tracheal  intubation,  and  additional  boluses  were  pro-
ided,  if  needed.  No  written  policy  exists  concerning
he  use  of  neuromuscular  monitoring  so  this  was  per-
ormed  at  the  discretion  of  the  anesthesiologist.  To
nsure  that  the  anesthesiologist  remained  blinded  to
he  patients’  participation  in  the  study,  we  did  not
ttempt  to  observe  the  use  or  interpretation  of  TOF
ntraoperatively.  The  anesthesiologist  was  free  to  decide
hether  to  reverse  the  neuromuscular  blockade  (NMB)
ith  neostigmine  at  the  conclusion  of  the  surgical  proce-
ure.
Usually,  the  patient  was  extubated  in  the  operating  room
nd  transferred  to  the  PACU.  Criteria  for  extubation  included
ustained  head  lift  or  hand  grip  for  more  than  5  s,  the  abil-
ty  to  follow  simple  commands,  a  stable  ventilatory  pattern
ith  acceptable  arterial  oxygen  saturation  (SpO2) >  95%,  and
 TOF  ratio  greater  than  0.80.  All  subjects  were  adminis-
ered  100%  oxygen  by  a  facemask  after  tracheal  extubation.
he  anesthesiologist  was  free  to  decide  whether  to  admin-
ster  oxygen  during  the  time  between  transfer  to  the  cart
nd  admission  to  the  PACU.
Upon  arrival  at  the  PACU  all  subjects  were  provided  with
xygen  either  by  a  nasal  cannula  or  face  mask.
A  standardized  data  collection  sheet  was  completed  for
ach  patient.  The  recorded  patient  characteristics  were:
ge,  weight,  height,  body  mass  index  (BMI),  benzodiazepine
dministration  before  surgery,  chronic  benzodiazepine  use,
ite  of  surgery  (intra-abdominal,  musculoskeletal  or  head
nd  neck),  American  Society  of  Anesthesiologists  physical
tatus  (ASA-PS),  Revised  Cardiac  Risk  Index  (RCRI),  drug
r  alcohol  abuse,  duration  of  preoperative  ﬂuid  fasting,
ype  of  anesthesia,  duration  of  surgery,  use  of  nitrous
xide,  adverse  respiratory  events  in  the  PACU,  postoperative
ain  level  (VAS  score),  postoperative  nausea  and  vomit-
ng  6  hours  after  surgery  and  24  h  after  surgery,  length  of
tay  in  the  PACU,  and  postoperative  length  of  stay  in  hospi-
al.
The  surgical  procedure  was  classiﬁed  in  terms  of  mag-
itude,  as  major  (surgery  in  which  body  cavities  or  major
essels  are  exposed  to  ambient  temperature  such  as  major
bdominal,  thoracic,  or  major  vascular,  thoracic  spine
urgery  with  instrumentation,  or  hip  arthroplasty),  medium
surgery  in  which  body  cavities  are  exposed  to  a  lesser
6
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egree  such  as  appendectomy),  and  minor  surgery  (super-
cial  surgery).  Major  surgery  was  deﬁned  as  a  surgery
equiring  a  hospital  stay  of  2  or  more  days.
Clinical  risk  factors  (a  history  of  ischemic  heart  dis-
ase,  history  of  compensated  or  prior  heart  failure,  history
f  cerebrovascular  disease,  diabetes  mellitus,  and  renal
nsufﬁciency)  and  surgical  risk  (high-risk  deﬁned  as  intratho-
acic,  intraperitoneal,  or  suprainguinal  vascular  surgery,  or
urgery  involving  large  blood  loss  or  ﬂuid  shifts)  were  deﬁned
ccording  to  the  Cardiac  Risk  Stratiﬁcation  for  Noncardiac
urgical  Procedures  of  the  2007  guidelines  on  Perioperative
ardiovascular  Evaluation  and  Care  for  Noncardiac  Surgery
f  the  American  College  of  Cardiology/American  Heart  Asso-
iation  Task  Force  on  Practice  Guidelines.9
Data  for  other  preoperative  clinical  information
egarding  chronic  obstructive  pulmonary  disease  (COPD),
ypertension  and  dyslipidemia  were  collected  from  rou-
ine  clinical  documentation  entered  into  the  institution’s
erioperative  clinical  information  system.
Residual  neuromuscular  blocking  was  deﬁned  as  a
OF  <  0.9  and  it  was  quantiﬁed  at  admission  to  the  PACU
sing  acceleromyography  of  the  adductor  pollicis  muscle
TOF-Watch®).10,11
The  patients  were  screened  for  delirium  at  PACU  dis-
harge  and  in  the  ward  the  next  day  after  surgery  using
he  nursing  delirium  screening  scale  (Nu-DESC).12 Patients
ith  a  Nu-DESC  score  of  2  or  more  points  during  at  least
t  1  evaluation  were  considered  delirium  positive.  Patients
ere  tested  for  delirium  by  the  research  team  at  the  time
hey  were  formally  declared  to  be  ‘ready  for  discharge’  to
he  regular  ward  by  the  physician  in  charge  of  the  recovery
oom.  In  addition,  the  patients  were  seen  on  the  morning  of
he  ﬁrst  postoperative  day.
ostoperative  respiratory  complications
ach  postoperative  ARE  was  deﬁned  on  the  data  collection
heet  using  the  following  criteria  according  to  the  classiﬁ-
ation  described  by  Murphy  et  al13:
.  Upper  airway  obstruction  requiring  an  intervention  (jaw
thrust,  or  oral  or  nasal  airway);
.  Mild-moderate  hypoxia  (SpO2 of  93--90%)  on  3  L  nasal  can-
nula  O2 that  was  not  improved  after  active  interventions
(increasing  O2 ﬂows  to  >3  L/min,  application  of  high-ﬂow
face  mask  O2,  verbal  requests  to  breathe  deeply  and
tactile  stimulation);
.  Severe  hypoxia  (SpO2 <  90%)  on  3  L  nasal  cannula  O2 that
was  not  improved  after  active  interventions  (increasing
O2 ﬂows  to  >3  L/min,  application  of  high-ﬂow  facemask
O2,  verbal  requests  to  breathe  deeply,  and  tactile  stim-
ulation);
.  Signs  of  respiratory  distress  or  impending  ventilatory  fail-
ure  (respiratory  rate  >20  breaths  per  minute,  accessory
muscle  use,  and  tracheal  tug);
.  Inability  to  breathe  deeply  when  requested  to  by  the
PACU  nurse;. Patient  complaining  of  symptoms  of  respiratory  or  upper
airway  muscle  weakness  (difﬁculty  breathing,  swallow-
ing,  or  speaking);
.  Patient  requiring  reintubation  in  the  PACU;
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8.  Clinical  evidence  or  suspicion  of  pulmonary  aspiration
after  tracheal  extubation  (gastric  contents  observed  in
the  oropharynx  and  hypoxemia).
The  PACU  nurses  observed  the  patients  continuously
during  the  PACU  stay  and  contacted  a  study  investigator
immediately  if  an  ARE  was  observed.  The  inability  to  breathe
deeply  and  the  assessment  of  symptoms  of  respiratory  or
upper  airway  muscle  weakness  were  assessed  at  10-minute
intervals.  A  study  investigator  examined  the  patient  to  con-
ﬁrm  that  the  patient  met  at  least  one  of  the  criteria  for  an
ARE.
Statistical  method
Descriptive  analysis  of  variables  was  used  to  summarize
data.  Ordinal  and  continuous  data  found  not  to  follow  a
normal  distribution,  based  on  the  Kolmogorov--Smirnov  test
for  normality  of  the  underlying  population,  are  presented  as
median  and  interquartile  range.  Normally  distributed  data
are  presented  as  mean  and  standard  deviation  (SD).
A  univariate  analysis  was  performed  to  identify  differ-
ences  between  HR-OSA  and  LR-OSA  patients  by  using  the
Mann--Whitney  U-test  to  compare  continuous  variables  and
the  Chi-square  or  Fisher’s  exact  test  to  compare  propor-
tions  between  the  2  groups  of  subjects.  Differences  were
considered  statistically  signiﬁcant  when  P  was  <0.05.
A  univariate  analysis  was  performed  to  identify  predictors
for  ARE.
Multiple  regression  binary  logistic  was  used  with  forward
conditional  method  in  the  model  in  order  to  identify  inde-
pendent  predictors  for  ARE.  In  this  model,  all  covariates
with  p  <  0.05  in  the  univariate  analyses  were  entered  and  an
odds  ratio  (OR)  and  95%  Conﬁdence  Interval  (95%  CI)  were
calculated.
Data  were  analyzed  using  SPSS  software  for  Windows  Ver-
sion  19.0  (SPSS  Inc.,  Chicago,  IL,  USA).
Results
From  the  357  patients  consecutively  admitted  to  the  PACU
during  the  study  period,  a  total  of  340  patients  were  studied.
Seventeen  patients  were  excluded:  7  patients  were  admit-
ted  to  a  surgical  intensive  care  unit,  3  patients  were  unable
to  provide  informed  consent  or  had  a  MMSE  <25,  3  patients
did  not  undergo  surgery,  1  patient  underwent  neurosurgery,
1  patient  was  less  than  18  years  old,  1  patient  did  not  speak
Portuguese  and  1  patient  refused  to  participate.
Of  the  340  patients  included  in  the  analysis  (Table  1),  179
(52%)  were  classiﬁed  as  HR-OSA.  These  patients  were  older
(mean  age  of  61.7  ±  13.4  vs.  48.8  ±  16.0  years  and  median
age  63  vs.  47  years,  p  <  0.001),  were  more  likely  to  be  men
(63%  vs.  21%,  p  <  0.001),  had  higher  BMI  (mean  29.1  ±  6.0  vs.
25.1  ±  4.4  kg/m2,  median  28  vs.  24  kg/m2,  p  <  0.001)  higher
ASA  physical  status  (ASA  III,  IV  or  V  26%  vs.  10%,  p  <  0.001)
and  higher  RCRI  scores  (RCRI  >  2  in  7%  vs.  2%).  Patients  with
HR-OSA  had  a  higher  incidence  of  ischemic  heart  disease
(10%  vs.  2%,  p  =  0.001),  heart  failure  (8%  vs.  3%,  p  =  0.032),
hypertension  (62%  vs.  19%,  p  <  0.001),  dyslipidemia  (41%  vs.
12%,  p  <  0.001)  and  underwent  more  frequently  insulin  treat-
ment  for  diabetes  (24%  vs.  4%,  p  <  0.001).  The  prevalence  of
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erebrovascular  disease  (4%  vs.  1%,  p  =  0.116)  and  preoper-
tive  serum  creatinine  >2  mg/dl  (6%  vs.  4%,  p  =  0.394)  were
ot  signiﬁcantly  different  between  the  2  groups.
HR-OSA  patients  were  more  likely  to  undergo  intra-
bdominal  surgery  (43%  vs.  29%,  p  =  0.011)  and  surgery  of
ajor  magnitude  (32%  vs.  22%,  p  =  0.033),  had  more  fre-
uently  loco  regional  anesthesia  as  a  unique  technique  (26%
s.  14%,  p  =  0.009)  and  less  frequently  had  general  or  com-
ined  general  and  loco  regional  anesthesia  (74%  vs.  86%,
 =  0.009).  Patients  classiﬁed  as  HR-OSA  had  a  higher  inci-
ence  of  residual  NMB  (RNMB)  (20%  vs.  16%,  p  =  0.035).
In  relation  to  respiratory  events  (Table  2)  that  occurred  in
he  PACU,  HR-OSA  patients  had  more  frequently  experienced
ild/moderated  hypoxia  (9%  vs.  3%,  p  =  0.012).  The  length
f  the  hospital  stay  (median  5  days  vs.  3  days,  p  =  0.01),  but
ot  the  length  of  the  PACU  stay  (96  vs.  91  minutes,  p  =  0.064),
as  higher  in  these  patients.
In  multivariate  analyses  for  ARE  occurrence  (Table  3)  and
fter  adjustment  for  univariate  predictors  (gender,  intra-
bdominal  surgery,  major  surgery,  cardiovascular  high-risk
urgery,  general  anesthesia  and/or  combined  anesthesia,
se  of  neuromuscular  relaxants  and  postoperative  resid-
al  neuromuscular  blockade)  the  occurrence  of  residual
euromuscular  blockade  was  identiﬁed  as  an  independent
redictor  of  ARE.
In  these  analyses  HR-OSA  was  not  a  determinant  for  ARE
p  =  0.142)  and  was  not  entered  in  the  multivariate  model.
R-OSA  is  shown  in  Table  3  but  it  was  not  introduced  in
he  model  because  it  was  not  considered  determinant  for
RE.
iscussion
he  incidence  of  patients  with  HR-OSA  was  52%  in  our  study,
hich  indicates  that  this  is  an  important  matter  for  concern
mong  patients  scheduled  for  surgery  in  our  hospital.
We  relied  on  a  STOP-BANG  score  ≥  3  for  this  study,  since
his  was  demonstrated  to  be  a  highly  sensitive  test  for  mod-
rate/severe  OSA.  Indeed,  Chung  et  al.14 suggested  that  this
ut-off  is  appropriate  for  the  surgical  population14 and  fur-
her  stated  that  the  STOP-BANG  questionnaire  is  concise,
asy  to  use,  and  its  importance  lies  in  the  identiﬁcation
f  patients  at  high  risk  of  OSA  which  may  help  to  prevent
ostoperative  complications.
The  HR-OSA  group  of  patients  had  a  signiﬁcantly
igher  percentage  of  men  and  as  expected  the  BMI  was
igniﬁcantly  different  between  the  LR-OSA  and  HR-OSA
roups  (p  <  0.001).  Similar  results  have  been  reported
reviously.15,16 The  importance  of  these  ﬁndings  is  revealed
y  the  presence  of  these  variables  in  different  tools  such
s  the  sleep  apnea  clinical  score  (SACS)  and  even  the  STOP-
ANG,  used  to  assess  OSA  severity.
The  association  between  increased  morbidity  and
ntreated  OSA  is  well  established,  which  may  result  in  an
ncreased  mortality  rate.17,18 Furthermore,  these  patients
re  at  a  greater  risk  of  developing  cardiovascular  dis-
ase.  Indeed,  HR-OSA  patients  had  more  frequently  cardiac
omorbidities  (ischemic  heart  disease  and  congestive  heart
ailure),  hypertension,  dyslipidaemia  and  pulmonary  chronic
isease  in  our  study.  These  comorbidities  may,  however,
ave  reﬂected  higher  ASA  and  RCRI  scores,  which  would
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Table  1  Patient  baseline  characteristics  (n  =  340).
Variable  HR-OSA  (n  =  179)  LR-OSA  n  =  161  p
Age,  median  (IQR)  63  (55--71)  47  (36--61)  <0.001c
Gender,  n  (%)  <0.001a
Male  113  (63)  33  (21)
Female 66  (37)  128  (80)
Site of  Surgery,  n  (%)
Intraabdominal  76  (43)  47  (29)  0.011a
Musculoskeletal  88  (49) 91  (57) 0.175a
Head  and  Neck 15  (8) 23  (14) 0.084a
Body  mass  index  (kg/m2),  median  (IQR) 28  (25--32) 24  (22--28) <0.001c
ASA  physical  status,  n  (%) <0.001a
I/II  132  (74)  145  (90)
III/IV/V, n  (%)  47  (26)  16  (10)
High risk  surgery,  n  (%) 57  (32)  36  (22)  0.050a
Ischemic  heart  disease,  n  (%) 18  (10) 3  (2)  0.001b
Congestive  heart  disease,  n  (%) 15  (8) 5  (3)  0.032b
Cerebrovascular  disease,  n  (%) 7  (4) 2  (1)  0.116b
Insulin  therapy  for  diabetes,  n  (%) 42  (24) 7  (4) <0.001a
Renal  insufﬁciency,  n  (%) 10  (6) 7  (4) 0.394a
RCRI,  n  (%)  0.030b
RCRI  ≤  2  167(93)  158  (98)
RCRI >  2  12  (7)  3  (2)
Hypertension,  n  (%)  111(62)  30  (19)  <0.001a
Dyslipidemia,  n  (%)  73(41)  19  (12)  <0.001a
COPD,  n  (%)  15  (8)  4  (3)  0.015b
Type  of  anesthesia,  n  (%)  0.009a
Loco  regional  46  (26)  23  (14)
General/combined  133  (74)  138  (86)
Magnitude of  surgery,  n  (%)
Minor  14  (8)  21  (13)  0.114a
Medium  108  (63)  104  (65)  0.481a
Major  57  (32)  36  (22)  0.033a
Bariatric  surgery,  n  (%)  12  (7)  2  (1)  0.016b
Duration  surgery,  median  (IQR)  87  (50--135)  75  (50--120)  0.173c
Post-operative  delirium  hospital,  n  (%)  23  (13)  16  (10)  0.400a
Temperature  on  admission,  median  (IQR)  35.3  (34.9--35.7)  35.4  (34.9--35.7)  0.158c
<35 ◦C,  n  (%)  6  (25)  104  (33)  0.424a
Length  of  PACU  stay  minutes,  median  (IQR)  96  (67--145)  91  (65--120)  0.064c
Length  of  Hospital  stay  (days),  median  (IQR)  5  (2--8)  3  (2--6)  0.010c
Perioperative  muscle  relaxants  use,  n(%)  99  (55)  106  (66)  0.048a
Neuromuscular  residual  blocking,  n  (%)  35(20)  25  (16)  0.035a
a Pearson’s chi-squared test.
b Fisher’s exact test.
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cMann--Whitney U-test IQR, interquartile range HR-OSA, high-r
cardiac risk index; COPD, Chronic Pulmonary Obstructive Disease;
ndirectly  indicate  the  presence  of  more  important  associ-
ted  comorbidities  in  patients  at  a  higher  risk  of  having  OSA.
Our  results  show  that  HR-OSA  patients  more  frequently
nderwent  bariatric  surgery,  abdominal  surgery,  and  major
urgery.  Thus,  it  is  possible  that  the  risks  associated  with
ajor  surgery  and  bariatric  surgery  may  account  for  the
igher  complication  rates  rather  than  the  diagnosis  of  HR-
SA  in  itself.
f
i
a OSA; ASA, American Society of Anesthesiologists; RCRI, revised
, Post Anesthesia Care Unit.
We  found  that  the  length  of  the  hospital  stay  was  higher
n  HR-OSA  patients,  which  is  in  agreement  with  the  study  of
iu  et  al.19 This  suggests  postoperative  hypoxemia  is  asso-
iated  with  adverse  outcomes  including  the  need  for  more
requent  respiratory  interventions  and  more  intensive  mon-
toring  which  may  led  to  a  longer  hospital  stay
The  incidence  of  RNMB  was  higher  in  HR-OSA  patients.  In
ddition,  a  higher  incidence  of  RNMB  was  found  in  patients
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Table  2  Respiratory  complications  (n  =  340).
Variable  All  (n  =  340)  HR-OSA  n  =  179  LR-OSA  n  =  161  p
Respiratory  events  64  (19)  39  (22)  25  (16)  0.140
Obstruction  airway  3  (1)  1  (1)  2  (1)  0.475
Hypoxia (mild/moderate)  19  (6)  15  (9)  4  (3)  0.012
Hypoxia Severe  5  (2)  3  (2)  2  (1)  0.529
Respiratory  failure  7  (2)  5  (3)  2  (1)  0.253
Inspiratory capacity  decreased 49(15)  28  (17)  21  (13)  0.407
Muscle weakness 11  (3) 8  (5) 3  (2) 0.132
Table  3  Multivariate  regression  analysis  for  predictors  of  adverse  respiratory  events.
Variable  Simple  OR  (95%  CI)  p bOR  (95%  CI)  pa
Gender  1.9  (1.0--3.3) 0.038 --
Intra-abdominal  surgery 1.8  (1.0--3.0) 0.049 --
General/combined  anesthesia 2.9  (1.3-- 6.6) 0.013 -- --
NMBD  use 2.8  (1.5--5.3) 0.002 -- --
RNMB  6.1  (3.1  --12.2) <0.001 5.9  (2.8--12.5) <0.001
High risk  surgery  2.3  (1.3--4.1)  0.004  --  --
Major surgery  1.8  (1.0--3.2)  0.045  --  --
HR-OSA 1.5  (0.9--2.6)  0.145  --  --
a Logistic regression analysis with forward conditional elimination method was used with an entry criterion of p < 0.05.
OR; odds ratio; CI, Conﬁdence Interval; NMBD, neuromuscular blocking drugs; RNMB, residual neuromuscular blockade.
b Adjusted OR for gender, intra-abdominal surgery, high-risk surgery, major surgery, NMBD use and RNMB (variables considered to be
determinants for ARE in a univariate analyses).
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-with  a  high  BMI,20,21 which  may  be  due  to  the  accumulation
of  neuromuscular  blocker  in  the  adipose  tissue.  These  data
suggest  that  enhanced  monitoring  is  important  when  HR-OSA
patients  are  exposed  to  additional  risk  factors  for  respiratory
complications  like  RNMB,  or  when  these  patients  are  given
drugs  that  enhance  neuromuscular  blockade.
Perioperative  complications,  including  respiratory
events,  were  more  frequent  in  patients  with  HR-OSA.
Compared  with  patients  without  this  diagnosis,  we  found
that  the  HR-OSA  patients  more  frequently  experienced
mild/moderated  hypoxia  in  the  PACU  and  there  was  a
greater  risk  of  postoperative  hypoxemia  in  HR-OSA  patients
in  comparison  with  those  without  the  diagnosis.  This  is
consistent  with  the  results  of  the  study  of  Gali  et  al.,15
which  found  that  respiratory  events  were  more  frequent  in
patients  with  a  high  risk  of  OSA.  However,  in  our  study,  as  in
the  study  of  Chung  et  al.22 analysis  of  perioperative  adverse
events  did  not  show  signiﬁcant  respiratory  morbidity  in
HR-OSA  patients  compared  to  the  LR-OSA  patients.  In  fact
in  our  study  we  did  not  ﬁnd  that  HR-OSA  was  a  determinant
for  ARE.
This  study  has  several  limitations.  The  ﬁrst  and  most
important  limitation  is  that  it  was  not  possible  to  compare
the  results  of  the  STOP-BANG  questionnaire  with  a  deﬁnitive
polysomnographic  diagnosis.Second,  our  patients  may  have  been  at  high  risk  for
postoperative  events  without  having  OSA.  The  use  of  the
STOP-BANG  score  is  as  an  instrument  to  predict  the  risk  of
a  patient  to  having  OSA  may  have  led  to  a  high  incidence  of
-
-alse  positive  results.  It  is  possible  that  a  higher  score  should
ave  been  used  because  recent  studies  have  shown  that  the
TOP-BANG  score  has  a  higher  accuracy  in  detecting  moder-
te  to  severe  OSA  patients  in  a  surgical  population  when  the
core  is  greater  than  or  equal  to  5.1
Third,  the  respiratory  events  were  only  registered  in
he  PACU  and  complications  that  could  have  occurred  after
ACU  discharge  were  not  considered.  This  might  be  viewed
s  a  major  limitation  since  respiratory  complications  after
urgery  may  be  associated  with  adverse  outcomes  that  occur
uring  the  hospital  stay  after  PACU  discharge.
Fourth,  the  fact  that  HR-OSA  patients  more  frequently
nderwent  major  surgery  may  be  viewed  as  a  confounding
actor  and  a  limitation  of  the  study  because  it  indicates  that
he  patient  groups  were  non-homogeneous.
In  conclusion,  the  principal  ﬁndings  of  this  study  are  as
ollows:
 HR-OSA  patients  have  a  higher  incidence  of  postoperative
respiratory  complications;
 mild/moderate  hypoxia  was  the  most  frequent  pulmonary
adverse  event  in  the  immediate  postoperative  period  that
occurred  more  frequently  in  HR-OSA  patients;
 HR-OSA  patients  had  more  comorbidities  including
ischemic  heart  disease,  congestive  heart  failure,  diabetes
treated  with  insulin,  chronic  pulmonary  disease,  hyper-
tension  and  dyslipidemia;
 HR-OSA  patients  required  a  longer  stay  in  the  hospital.
 HR-OSA  was  not  a  determinant  for  ARE.
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